🇺🇸 SCIO-469 in United States

50 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Disease Progression — 8 reports (16%)
  2. Haemoglobin Decreased — 7 reports (14%)
  3. Asthenia — 5 reports (10%)
  4. Dizziness — 5 reports (10%)
  5. Pneumonia — 5 reports (10%)
  6. Dyspnoea — 4 reports (8%)
  7. Epistaxis — 4 reports (8%)
  8. Hypotension — 4 reports (8%)
  9. Multiple Myeloma — 4 reports (8%)
  10. Platelet Count Decreased — 4 reports (8%)

Source database →

Frequently asked questions

Is SCIO-469 approved in United States?

SCIO-469 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for SCIO-469 in United States?

Scios, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.